Mealey's (November 29, 2017, 12:27 PM EST) -- ALEXANDRIA, Va. — Allegations that 19 claims of a patent covering “injectable suspensions having improved injectability” would have been obvious to a person of skill in the art were rejected Nov. 28 by the Patent Trial and Appeal Board (Luye Pharma Group Ltd., et al. v. Alkermes Pharma Ireland Ltd., et al., No. IPR2016-01096, PTAB)....